We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
3.40 | 0.20% | 1,708.60 | 1,708.60 | 1,708.80 | 1,713.00 | 1,699.40 | 1,701.60 | 11,102,455 | 16:29:59 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.27 | 70.34B |
TIDMGSK
RNS Number : 5780W
GlaxoSmithKline PLC
11 December 2019
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them ('PCA') === =============================================================================== a) Name Ms E Walmsley === ============================ ================================================= b) Position/status Chief Executive Officer === ============================ ================================================= c) Initial notification/ Initial notification amendment === ============================ ================================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === =============================================================================== a) Name GlaxoSmithKline plc === ============================ ================================================= b) LEI 5493000HZTVUYLO1D793 === ============================ ================================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === =============================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ============================ ================================================= b) Nature of the Acquisition of Ordinary Shares under the transaction Company's Share Reward Plan. === ============================ ================================================= c) Price(s) and Price(s) Volume(s) volume(s) === ============================ ============== ============================= GBP17.3090 8 (partnership shares) === ============================ ============== ============================= GBP17.3090 8 (matching shares) ============== ============================= d) Aggregated information === Aggregated volume 16 Ordinary Shares Price GBP17.3090 === ============================ ================================================= e) Date of the transaction 2019-12-10 === ============================ ================================================= f) Place of the London Stock Exchange (XLON) transaction === ============================ ================================================= 1. Details of PDMR/person closely associated with them ('PCA') === =============================================================================== a) Name Mr R Connor === ============================ ================================================= b) Position/status President, Global Vaccines === ============================ ================================================= c) Initial notification/ Initial notification amendment === ============================ ================================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === =============================================================================== a) Name GlaxoSmithKline plc === ============================ ================================================= b) LEI 5493000HZTVUYLO1D793 === ============================ ================================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === =============================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ============================ ================================================= b) Nature of the Acquisition of Ordinary Shares under the transaction Company's Share Reward Plan. === ============================ ================================================= c) Price(s) and Price(s) Volume(s) volume(s) === ============================ ============== ============================= GBP17.3090 8 (partnership shares) === ============================ ============== ============================= GBP17.3090 8 (matching shares) ============== ============================= d) Aggregated information === Aggregated volume 16 Ordinary Shares Price GBP17.3090 === ============================ ================================================= e) Date of the transaction 2019-12-10 === ============================ ================================================= f) Place of the London Stock Exchange (XLON) transaction === ============================ ================================================= 1. Details of PDMR/person closely associated with them ('PCA') === =============================================================================== a) Name Ms D Conrad === ============================ ================================================= b) Position/status SVP, Human Resources === ============================ ================================================= c) Initial notification/ Initial notification amendment === ============================ ================================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === =============================================================================== a) Name GlaxoSmithKline plc === ============================ ================================================= b) LEI 5493000HZTVUYLO1D793 === ============================ ================================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === =============================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ============================ ================================================= b) Nature of the Acquisition of Ordinary Shares under the transaction Company's Share Reward Plan. === ============================ ================================================= c) Price(s) and Price(s) Volume(s) volume(s) === ============================ ============== ============================= GBP17.3090 8 (partnership shares) === ============================ ============== ============================= GBP17.3090 8 (matching shares) ============== ============================= d) Aggregated information === Aggregated volume 16 Ordinary Shares Price GBP17.3090 === ============================ ================================================= e) Date of the transaction 2019-12-10 === ============================ ================================================= f) Place of the London Stock Exchange (XLON) transaction === ============================ ================================================= 1. Details of PDMR/person closely associated with them ('PCA') === =============================================================================== a) Name Mr N Hirons === ============================ ================================================= b) Position/status SVP, Global Ethics and Compliance === ============================ ================================================= c) Initial notification/ Initial notification amendment === ============================ ================================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === =============================================================================== a) Name GlaxoSmithKline plc === ============================ ================================================= b) LEI 5493000HZTVUYLO1D793 === ============================ ================================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s) has been conducted === =============================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ============================ ================================================= b) Nature of the Acquisition of Ordinary Shares under the transaction Company's Share Reward Plan. === ============================ ================================================= c) Price(s) and Price(s) Volume(s) volume(s) === ============================ ============== ============================= GBP17.3090 8 (partnership shares) === ============================ ============== ============================= GBP17.3090 8 (matching shares) ============== ============================= d) Aggregated information === Aggregated volume 16 Ordinary Shares Price GBP17.3090 === ============================ ================================================= e) Date of the transaction 2019-12-10 === ============================ ================================================= f) Place of the London Stock Exchange (XLON) transaction === ============================ ================================================= 1. Details of PDMR/person closely associated with them ('PCA') === =============================================================================== a) Name Ms S Jackson === ============================ ================================================= b) Position/status SVP, Global Communications and CEO Office === ============================ ================================================= c) Initial notification/ Initial notification amendment === ============================ ================================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === =============================================================================== a) Name GlaxoSmithKline plc === ============================ ================================================= b) LEI 5493000HZTVUYLO1D793 === ============================ ================================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === =============================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ============================ ================================================= b) Nature of the Acquisition of Ordinary Shares under the transaction Company's Share Reward Plan. === ============================ ================================================= c) Price(s) and Price(s) Volume(s) volume(s) === ============================ ============== ============================= GBP17.3090 8 (partnership shares) === ============================ ============== ============================= GBP17.3090 8 (matching shares) ============== ============================= d) Aggregated information === Aggregated volume 16 Ordinary Shares Price GBP17.3090 === ============================ ================================================= e) Date of the transaction 2019-12-10 === ============================ ================================================= f) Place of the London Stock Exchange (XLON) transaction === ============================ ================================================= 1. Details of PDMR/person closely associated with them ('PCA') === =================================================================================== a) Name Mr D Jackson === ============================ ===================================================== b) Position/status PCA of Ms S Jackson (SVP, Global Communications and CEO Office) === ============================ ===================================================== c) Initial notification/ Initial notification amendment === ============================ ===================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === =================================================================================== a) Name GlaxoSmithKline plc === ============================ ===================================================== b) LEI 5493000HZTVUYLO1D793 === ============================ ===================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === =================================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ============================ ===================================================== b) Nature of the Acquisition of Ordinary Shares under the transaction Company's Share Reward Plan. === ============================ ===================================================== c) Price(s) and Price(s) Volume(s) volume(s) === ============================ ================ =============================== GBP17.3090 7 (partnership shares) === ============================ ================ =============================== GBP17.3090 7 (matching shares) ================ =============================== d) Aggregated information === Aggregated volume 14 Ordinary Shares Price GBP17.3090 === ============================ ===================================================== e) Date of the transaction 2019-12-10 === ============================ ===================================================== f) Place of the London Stock Exchange (XLON) transaction === ============================ ===================================================== 1. Details of PDMR/person closely associated with them ('PCA') === =============================================================================== a) Name Mr D Redfern === ============================ ================================================= b) Position/status Chief Strategy Officer === ============================ ================================================= c) Initial notification/ Initial notification amendment === ============================ ================================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === =============================================================================== a) Name GlaxoSmithKline plc === ============================ ================================================= b) LEI 5493000HZTVUYLO1D793 === ============================ ================================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === =============================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ============================ ================================================= b) Nature of the Acquisition of Ordinary Shares under the transaction Company's Share Reward Plan. === ============================ ================================================= c) Price(s) and Price(s) Volume(s) volume(s) === ============================ ============== ============================= GBP17.3090 8 (partnership shares) === ============================ ============== ============================= GBP17.3090 8 (matching shares) ============== ============================= d) Aggregated information === Aggregated volume 16 Ordinary Shares
Price GBP17.3090 === ============================ ================================================= e) Date of the transaction 2019-12-10 === ============================ ================================================= f) Place of the London Stock Exchange (XLON) transaction === ============================ ================================================= 1. Details of PDMR/person closely associated with them ('PCA') === =============================================================================== a) Name Mr R Simard === ============================ ================================================= b) Position/status President, Pharmaceutical Supply Chain === ============================ ================================================= c) Initial notification/ Initial notification amendment === ============================ ================================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === =============================================================================== a) Name GlaxoSmithKline plc === ============================ ================================================= b) LEI 5493000HZTVUYLO1D793 === ============================ ================================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === =============================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ============================ ================================================= b) Nature of the Acquisition of Ordinary Shares under the transaction Company's Share Reward Plan. === ============================ ================================================= c) Price(s) and Price(s) Volume(s) volume(s) === ============================ ============== ============================= GBP17.3090 7 (partnership shares) === ============================ ============== ============================= GBP17.3090 7 (matching shares) ============== ============================= d) Aggregated information === Aggregated volume 14 Ordinary Shares Price GBP17.3090 === ============================ ================================================= e) Date of the transaction 2019-12-10 === ============================ ================================================= f) Place of the London Stock Exchange (XLON) transaction === ============================ ================================================= 1. Details of PDMR/person closely associated with them ('PCA') === =============================================================================== a) Name Mr P Thomson === ============================ ================================================= b) Position/status President, Global Affairs === ============================ ================================================= c) Initial notification/ Initial notification amendment === ============================ ================================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === =============================================================================== a) Name GlaxoSmithKline plc === ============================ ================================================= b) LEI 5493000HZTVUYLO1D793 === ============================ ================================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === =============================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ============================ ================================================= b) Nature of the Acquisition of Ordinary Shares under the transaction Company's Share Reward Plan. === ============================ ================================================= c) Price(s) and Price(s) Volume(s) volume(s) === ============================ ============== ============================= GBP17.3090 7 (partnership shares) === ============================ ============== ============================= GBP17.3090 7 (matching shares) ============== ============================= d) Aggregated information === Aggregated volume 14 Ordinary Shares Price GBP17.3090 === ============================ ================================================= e) Date of the transaction 2019-12-10 === ============================ ================================================= f) Place of the London Stock Exchange (XLON) transaction === ============================ ================================================= 1. Details of PDMR/person closely associated with them ('PCA') === =============================================================================== a) Name Ms V Whyte === ============================ ================================================= b) Position/status Company Secretary === ============================ ================================================= c) Initial notification/ Initial notification amendment === ============================ ================================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === =============================================================================== a) Name GlaxoSmithKline plc === ============================ ================================================= b) LEI 5493000HZTVUYLO1D793 === ============================ ================================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === =============================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ============================ ================================================= b) Nature of the Acquisition of Ordinary Shares under the transaction Company's Share Reward Plan. === ============================ ================================================= c) Price(s) and Price(s) Volume(s) volume(s) === ============================ ============== ============================= GBP17.3090 8 (partnership shares) === ============================ ============== ============================= GBP17.3090 8 (matching shares) ============== ============================= d) Aggregated information === Aggregated volume 16 Ordinary Shares Price GBP17.3090 === ============================ ================================================= e) Date of the transaction 2019-12-10 === ============================ ================================================= f) Place of the London Stock Exchange (XLON) transaction === ============================ =================================================
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DSHQFLFFKLFEFBX
(END) Dow Jones Newswires
December 11, 2019 11:57 ET (16:57 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions